BioRestorative Therapies, Inc. has partnered with Access BIO to provide strategic preclinical and regulatory consulting services related to its brtxDISC program. Initially Access BIO will help BioRestorative prepare for pre-IND and IND meetings with the FDA to advance its brtxDISC procedure into the clinic.   Access BIO’s founder, Joy A. Cavagnaro, Ph.D., was a long-time senior regulator and policymaker at the FDA’s Center for Biologics Evaluation and Research (CBER).   “The engagement of Access...